AbbVie, Inc.
ABBV · NYSE · USD
$272.42
+1.06 0.39%todayNot financial advice.
- Open
- 270.98
- Day range
- 265.71 - 272.52
- 52-week range
- 190.75 - 274.94
- Volume
- 5.49M
- Market cap
- 481.4B
- P/E ratio
- 77.02
- EPS
- 3.54
- Dividend yield
- 2.52%
- Beta
- -0.66
Performance
W
+4.57%
1M
+8.17%
3M
+8.53%
6M
+27.57%
YTD
+19.10%
Y
+17.69%
5Y
+145.31%
All
+636.27%
In the news
Oct 8
Iambic Therapeutics Targets Over $800 Million Valuation In US IPO
AI drug discovery firm Iambic Therapeutics plans to raise up to $159 million in a Nasdaq IPO to advance its lead cancer treatment.
IPOs
Oct 8
FDA Fast-Tracks AbbVie Cancer Drug in Two Major Indications
AbbVie shares rose after the FDA granted two Breakthrough Therapy Designations to its experimental cancer treatment.
Company news
Oct 7
AbbVie Receives Two FDA Breakthrough Therapy Designations for Cancer Drug Temab-A
AbbVie received two FDA Breakthrough Therapy Designations for its oncology drug Temab-A, which could speed up development in large cancer markets.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NYSE-ABBV" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="AbbVie, Inc. (ABBV) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NYSE-ABBV">ABBV stock price</a> by FreeTheAI Stocks</p>